Sylogist Ltd. (TSE:SYZ - Free Report) - Equities research analysts at Ventum Cap Mkts lowered their Q2 2025 EPS estimates for Sylogist in a report issued on Thursday, May 15th. Ventum Cap Mkts analyst A. Ezzat now forecasts that the company will post earnings of ($0.01) per share for the quarter, down from their previous forecast of $0.03. The consensus estimate for Sylogist's current full-year earnings is $0.24 per share. Ventum Cap Mkts also issued estimates for Sylogist's Q3 2025 earnings at $0.03 EPS and Q4 2025 earnings at $0.05 EPS.
Sylogist Trading Down 3.4%
Sylogist stock traded down C$0.32 during mid-day trading on Monday, hitting C$8.97. The company's stock had a trading volume of 5,727 shares, compared to its average volume of 48,117. Sylogist has a 12 month low of C$6.33 and a 12 month high of C$11.60. The company has a debt-to-equity ratio of 47.19, a current ratio of 0.54 and a quick ratio of 0.51. The business has a 50 day moving average price of C$8.51 and a 200-day moving average price of C$9.27. The stock has a market cap of C$212.10 million, a price-to-earnings ratio of 199.06 and a beta of 0.82.
Sylogist Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, March 12th. Stockholders of record on Wednesday, March 12th were paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.45%. The ex-dividend date was Friday, February 28th. Sylogist's dividend payout ratio (DPR) is presently 88.77%.
About Sylogist
(
Get Free Report)
Sylogist Ltd., a software company, provides mission-critical software-as-a-service solutions in Canada, the United States, and the United Kingdom. The company offers SylogistMission constituent relationship management system, which includes donor management, fundraising, volunteer management, and program delivery; and enterprise resource management, such as accounting and financial management, grant and award management, budget management, payroll and human resources, analytics and reporting, and support and training.
Recommended Stories
Before you consider Sylogist, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sylogist wasn't on the list.
While Sylogist currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
